tiprankstipranks
pc:oncoc

OncoC4 Inc

Therapeutics
OncoC4 Inc is a clinical-stage biotechnology company focused on the development of innovative cancer immunotherapies. The company is dedicated to advancing its pipeline of novel therapeutic candidates designed to harness the power of the immune system to target and eliminate cancer cells, aiming to improve treatment outcomes for patients with various types of cancer.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$50M
Total Amount Raised$50M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$50M
Latest Funding Amount$50M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.
1.MRKMerck & Co Inc
2.BNTXBioNTech SE
1.MRKMerck & Co Inc
2.BNTXBioNTech SE

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 02, 2025
Series B
$50.00M
―

Investors

Investor Name
Funding Round
3E Bioventures Capital
Series B
GBA Fund
Series B
HM Capital
Series B
Kaitai Capital
Series B

Related News and Analysis

Florida AG Targets OpenAI in Probe Over Alleged ChatGPT Role in Campus Shooting

Florida AG Targets OpenAI in Probe Over Alleged ChatGPT Role in Campus Shooting

New updates have been reported about OpenAI. Florida Attorney General James Uthmeier has opened an investigation into OpenAI...
1h ago
OPAIQ
Aledade’s Culture Wins National Recognition, Bolstering Its Value-Based Care Strategy

Aledade’s Culture Wins National Recognition, Bolstering Its Value-Based Care Strategy

New updates have been reported about Aledade. Aledade has secured a 2026 USA Today Top Workplaces award, spotlighting...
2h ago
ALEDE
Congruence Therapeutics Targets Investors at Needham Virtual Healthcare Conference

Congruence Therapeutics Targets Investors at Needham Virtual Healthcare Conference

New updates have been reported about Congruence Therapeutics. Congruence Therapeutics will seek to deepen its investor engagement at...
3h ago
CONGR
Tipalti Highlights SAP-Focused AP Automation and Navigator Partnership in Upcoming Webinar

Tipalti Highlights SAP-Focused AP Automation and Navigator Partnership in Upcoming Webinar

According to a recent LinkedIn post from Tipalti, the company is promoting a free 30-minute webinar on April...
6h ago
TIPAL
AmplifAI Highlights Strategic Alignment With Dataiku’s Enterprise AI Platform

AmplifAI Highlights Strategic Alignment With Dataiku’s Enterprise AI Platform

A LinkedIn post from AmplifAI discusses Dataiku’s newly launched “Platform for AI Success” and its relevance for enterprise...
6h ago
AMPLI
Axtria Highlights Role in Analytics-Focused Pharma Conference Attendance

Axtria Highlights Role in Analytics-Focused Pharma Conference Attendance

According to a recent LinkedIn post from Axtria, the company plans to participate in the Pharmaceutical Management Science...
6h ago
AXTRI
Celonis Enhances Process Platform With New Value Tracking and AI Features

Celonis Enhances Process Platform With New Value Tracking and AI Features

A LinkedIn post from Celonis highlights new product updates aimed at tightening the link between process visibility, artificial...
6h ago
CLONS
Media Coverage Underscores Growing Focus on Sepsis Diagnostics and Risk Assessment

Media Coverage Underscores Growing Focus on Sepsis Diagnostics and Risk Assessment

A LinkedIn post from Cytovale highlights media coverage examining the difficulty of recognizing sepsis in emergency departments. The...
6h ago
CYTOV
AppZen Highlights AI-Driven AP Automation Aimed at Faster Deployment

AppZen Highlights AI-Driven AP Automation Aimed at Faster Deployment

According to a recent LinkedIn post from AppZen, the company is highlighting its AP Inbox Service Center as...
6h ago
APPZE
Deel Launches Global Startup Investment Competition

Deel Launches Global Startup Investment Competition

According to a recent LinkedIn post from Deel, the company is promoting “The Pitch by Deel,” an investment-focused...
6h ago
DEELX